These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23003680)

  • 21. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.
    Lai SK; O'Hanlon DE; Harrold S; Man ST; Wang YY; Cone R; Hanes J
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1482-7. PubMed ID: 17244708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Sci; 2016 Oct; 93():410-8. PubMed ID: 27559026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods to determine the interactions of micro- and nanoparticles with mucus.
    Grießinger J; Dünnhaupt S; Cattoz B; Griffiths P; Oh S; Borrós i Gómez S; Wilcox M; Pearson J; Gumbleton M; Abdulkarim M; Pereira de Sousa I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Oct; 96():464-76. PubMed ID: 25641005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls.
    Nafee N; Forier K; Braeckmans K; Schneider M
    Eur J Pharm Biopharm; 2018 Mar; 124():125-137. PubMed ID: 29291931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orientation of a TICT probe trapped in the peripheral confined water created by ionic surfactant envelope around silver nanoparticles.
    Maity A; Jaffer SS; Das T; Ghosh P; Purkayastha P
    Langmuir; 2011 Apr; 27(7):4068-75. PubMed ID: 21344898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between surfactants and silver nanoparticles of varying charge.
    Hedberg J; Lundin M; Lowe T; Blomberg E; Wold S; Wallinder IO
    J Colloid Interface Sci; 2012 Mar; 369(1):193-201. PubMed ID: 22204969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of nanoparticles to the clathrin-mediated endocytic pathway.
    Harush-Frenkel O; Debotton N; Benita S; Altschuler Y
    Biochem Biophys Res Commun; 2007 Feb; 353(1):26-32. PubMed ID: 17184736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
    Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
    Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.
    Yue ZG; Wei W; Lv PP; Yue H; Wang LY; Su ZG; Ma GH
    Biomacromolecules; 2011 Jul; 12(7):2440-6. PubMed ID: 21657799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge.
    Hühn D; Kantner K; Geidel C; Brandholt S; De Cock I; Soenen SJ; Rivera Gil P; Montenegro JM; Braeckmans K; Müllen K; Nienhaus GU; Klapper M; Parak WJ
    ACS Nano; 2013 Apr; 7(4):3253-63. PubMed ID: 23566380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus.
    Lafitte G; Thuresson K; Jarwoll P; Nydén M
    Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.
    Kedmi R; Ben-Arie N; Peer D
    Biomaterials; 2010 Sep; 31(26):6867-75. PubMed ID: 20541799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; Smythe SC; McCord K; Mitchnick M; Kaptur PE; Romano J
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1181-90. PubMed ID: 20854207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery.
    Harush-Frenkel O; Bivas-Benita M; Nassar T; Springer C; Sherman Y; Avital A; Altschuler Y; Borlak J; Benita S
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):83-90. PubMed ID: 20417650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.